Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 Study Group. Ison MG, et al. Among authors: langley jm. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. Clin Infect Dis. 2024. PMID: 38253338 Free PMC article. Clinical Trial.
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM. Shoukat A, et al. Among authors: langley jm. Lancet Reg Health Am. 2023 Nov 9;28:100629. doi: 10.1016/j.lana.2023.100629. eCollection 2023 Dec. Lancet Reg Health Am. 2023. PMID: 38026446 Free PMC article.
PreHevbrio: the first approved 3-antigen hepatitis B vaccine.
Vesikari T, Langley JM, Popovic V, Diaz-Mitoma F. Vesikari T, et al. Among authors: langley jm. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1041-1054. doi: 10.1080/14760584.2023.2274482. Epub 2023 Nov 6. Expert Rev Vaccines. 2023. PMID: 37877189 Free article. Review.
Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic.
Bourdeau M, Vadlamudi NK, Bastien N, Embree J, Halperin SA, Jadavji T, Kazmi K, Langley JM, Lebel MH, Le Saux N, Moore D, Morris SK, Pernica JM, Robinson J, Sadarangani M, Bettinger JA, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Bourdeau M, et al. Among authors: langley jm. JAMA Netw Open. 2023 Oct 2;6(10):e2336863. doi: 10.1001/jamanetworkopen.2023.36863. JAMA Netw Open. 2023. PMID: 37792376 Free PMC article.
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Moghadas SM, et al. Among authors: langley jm. medRxiv [Preprint]. 2023 Aug 16:2023.08.14.23294076. doi: 10.1101/2023.08.14.23294076. medRxiv. 2023. Update in: Clin Infect Dis. 2024 May 15;78(5):1328-1335. doi: 10.1093/cid/ciad658. PMID: 37645896 Free PMC article. Updated. Preprint.
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial.
Sáez-Llorens X, Norero X, Mussi-Pinhata MM, Luciani K, de la Cueva IS, Díez-Domingo J, Lopez-Medina E, Epalza C, Brzostek J, Szymański H, Boucher FD, Cetin BS, De Leon T, Dinleyici EC, Gabriel MÁM, Ince T, Macias-Parra M, Langley JM, Martinón-Torres F, Rämet M, Kuchar E, Pinto J, Puthanakit T, Baquero-Artigao F, Gattinara GC, Arribas JMM, Ramos Amador JT, Szenborn L, Tapiero B, Anderson EJ, Campbell JD, Faust SN, Nikic V, Zhou Y, Pu W, Friel D, Dieussaert I, Lopez AG, McPhee R, Stoszek SK, Vanhoutte N. Sáez-Llorens X, et al. Among authors: langley jm. J Infect Dis. 2024 Jan 12;229(1):95-107. doi: 10.1093/infdis/jiad271. J Infect Dis. 2024. PMID: 37477875 Free PMC article. Clinical Trial.
245 results